library.onepin.app/ovagen Peptide Education Library

Education only, not medical advice◆ 21+◆ Every dose is an example to finalize with a licensed provider

OnePin Peptide Library · Bioregulators

Bioregulators Khavinson bioregulator tripeptide Not FDA-approved · investigational

Ovagen

Ovagen (Khavinson)

Khavinson bioregulator tripeptideLiver/GI tissue regulatorHepatic and digestive gene modulator

Ovagen (Lys-Glu-Asp) is a Khavinson bioregulator tripeptide targeting liver and gastrointestinal tissue gene expression. It overlaps with Livagen (liver-focused) but has broader hepatic and GI tissue targeting. Supports hepatocyte function, GI epithelial maintenance, and digestive system health.

Quick Start

Route

SubQ injection

Start low

5 mg daily

Frequency

Daily for 10-20 day course

Timing

No fasting required

SubQ injection, any time of day. 10-20 day courses, 2-3 cycles per year with 4-6 months between courses (Khavinson protocol). Pin alone or with other bioregulators only.

❋

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first

Quick Start

Conservative start

5 mg daily · SubQ injection · Daily for 10-20 day course

Lowest starting point. Hold about a week to assess tolerance before stepping up.

5 mg daily

Daily for 10-20 day course

Standard

Liver Regeneration

10-20 mg · Oral · Daily

anecdotal · community

10-20 mg

Daily

Reconstitution CalculatorU-100

Vial strength

BAC water

Target dose

050100u

Draw to

— units

◆

How it works

Ovagen modulates gene expression in hepatocytes and GI epithelial cells, supporting liver detoxification pathways, GI barrier integrity, and digestive enzyme production at the gene level.

What to expect

Early

Days 1–7

Days 1-10: Gene changes initiated.

Mid

Weeks 2–4

Weeks 2-8: Hepatic/GI gene programs established.

Later

Weeks 4–12

Months: Sustained support.

Evidence

HumanPresent

AnimalPresent

In-vitroPresent

2021Peptide Regulation of Gene Expression: A Systematic Review · Khavinson V et al, Molecules ↗review

2013Peptide bioregulators: the new class of geroprotectors. Communication 1. Results of experimental studies · Khavinson VKh et al, Advances in Gerontology ↗review

2009Peptide regulation of aging: 35-year research experience · Khavinson VKh, Bulletin of Experimental Biology and Medicine ↗review

The honest take

◆

Liver/GI dual support

Bioregulatory mechanism targeting both hepatic and GI tissue gene expression.

Interactions & stacking

What's safe to combine, and what belongs in a separate pin.

Safe & synergistic

BPC-157Ovagen targets liver/GI gene expression, BPC-157 drives GI mucosal repair. Complementary. Pin separately.

LivagenBoth target hepatic tissue. Can run in sequence for extended liver support.

Keep separate

ALL (syringe)PIN ALONE.

GHK-CuCopper degrades bioregulators.

Side effects & safety

Commonly reported

Very well tolerated

Less common & notes

Excellent safety profile.

Pharmacokinetics

Illustrative plasma concentration · 24 h

Half-life

0.5h

Peak · Tmax

0.05h

Elimination

2.5h

Activity

24-48 hours (gene expression changes persist beyond peptide clearance)

Storage. Standard BAC water 2-8C. 21-28 days.

Regulatory status

Not FDA-approved. Research peptide.

Put it to work

Calculate, log & track

Open Ovagen straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Ovagen in the app →

Go deeper

The guide & community

The complete Ovagen walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗

Open in app Community